Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TREM2 |
| Upstream (Parents) |
|---|
| (<<) S100A11 → TREM2 |
| (<<) SH3BGRL3 → TREM2 |
| (<<) CAPG → TREM2 |
| (<<) PLAU → TREM2 |
| (<<) GPNMB → TREM2 |
| (<<) OLR1 → TREM2 |
| Downstream (Children) |
|---|
| TREM2 → C19orf36 (>>) |
| TREM2 → HS3ST2 (>>) |
| TREM2 → CHIT1 (>>) |
| TREM2 → LPL (>>) |
| TREM2 → FAM70A (>>) |
| TREM2 → RGS10 (>>) |
| TREM2 → THNSL1 (>>) |
| TREM2 → NUDT4P1///NUDT4 (>>) |
| TREM2 → CXCR4 (>>) |
| TREM2 → CHST11 (>>) |
| TREM2 → GPNMB (>>) |
| TREM2 → SBNO2 (>>) |
| TREM2 → TBC1D2 (>>) |
| TREM2 → L2HGDH (>>) |
| TREM2 → CDC42EP4 (>>) |
| TREM2 → OLR1 (>>) |
| TREM2 → BFSP2 (>>) |
